UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$324M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$241M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$150M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$142M |
| 5 |
UBS Group
UBS
|
+$140M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$630M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$608M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$368M |
| 4 |
Tesla
TSLA
|
+$339M |
| 5 |
Amazon
AMZN
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.88% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.52% |
| 4 | Consumer Discretionary | 4.99% |
| 5 | Industrials | 4.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Extreme Networks
EXTR
$3.16B
| $464K | ﹤0.01% |
35,493
+33,875
| +2,094% | +$427K |
|
4402
Vanda Pharmaceuticals
VNDA
$304M
| $464K | ﹤0.01% |
47,003
-10,740
| -19% | -$113K |
|
|
BRW
4403
Saba Capital Income & Opportunities Fund
BRW
$335M
| $463K | ﹤0.01% |
58,449
-4,125
| -7% | -$33.8K |
|
4404
Ziff Davis
ZD
$1.92B
| $463K | ﹤0.01% |
6,766
-8,106
| -55% | -$638K |
|
4405
American Century Focused Large Cap Value ETF
FLV
$378M
| $462K | ﹤0.01% |
8,728
+4,663
| +115% | +$268K |
|
4406
Great Southern Bancorp
GSBC
$888M
| $461K | ﹤0.01% |
8,070
-326
| -4% | -$19.7K |
|
|
KDNY
4407
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $461K | ﹤0.01% |
23,448
+9,322
| +66% | +$187K |
|
4408
West Bancorporation
WTBA
$511M
| $460K | ﹤0.01% |
22,096
-5,613
| -20% | -$135K |
|
|
AVID
4409
DELISTED
Avid Technology Inc
AVID
| $460K | ﹤0.01% |
19,812
-1,059
| -5% | -$27.6K |
|
4410
iShares MSCI Japan Value ETF
EWJV
$756M
| $456K | ﹤0.01% |
21,059
-12,204
| -37% | -$288K |
|
4411
FTAI Infrastructure
FIP
$551M
| $456K | ﹤0.01% |
+189,973
| New | +$543K |
|
4412
Relay Therapeutics
RLAY
$4.37B
| $456K | ﹤0.01% |
20,426
-44,207
| -68% | -$970K |
|
|
DNMR
4413
DELISTED
Danimer Scientific, Inc.
DNMR
| $456K | ﹤0.01% |
3,864
-912
| -19% | -$162K |
|
4414
Invesco BulletShares 2029 Corporate Bond ETF
BSCT
$2.94B
| $455K | ﹤0.01% |
26,254
+5,963
| +29% | +$109K |
|
4415
Invesco DB Precious Metals Fund
DBP
$256M
| $455K | ﹤0.01% |
10,592
-12,217
| -54% | -$543K |
|
|
RNAM
4416
DELISTED
Avidity Biosciences
RNAM
| $455K | ﹤0.01% |
27,821
-13,258
| -32% | -$254K |
|
4417
CapForce IBD 50 ETF
FFTY
$80.5M
| $454K | ﹤0.01% |
18,579
-7,378
| -28% | -$204K |
|
4418
Kura Oncology
KURA
$896M
| $454K | ﹤0.01% |
33,231
-28,017
| -46% | -$432K |
|
4419
Forward Air
FWRD
$682M
| $453K | ﹤0.01% |
5,017
+417
| +9% | +$40.9K |
|
4420
LivePerson
LPSN
$35.9M
| $453K | ﹤0.01% |
3,204
-2,568
| -44% | -$492K |
|
4421
Construction Partners
ROAD
$6.73B
| $453K | ﹤0.01% |
17,256
+7,124
| +70% | +$187K |
|
|
STKL
4422
DELISTED
SunOpta
STKL
| $453K | ﹤0.01% |
49,748
+32,007
| +180% | +$304K |
|
|
VRE
4423
DELISTED
Veris Residential
VRE
| $453K | ﹤0.01% |
39,842
+29,860
| +299% | +$401K |
|
|
WIA
4424
Western Asset Inflation-Linked Income Fund
WIA
$187M
| $453K | ﹤0.01% |
50,630
-6,917
| -12% | -$69.4K |
|
|
FLC
4425
Flaherty & Crumrine Total Return Fund
FLC
$176M
| $452K | ﹤0.01% |
28,910
+469
| +2% | +$8.31K |
|
Similar funds
UBS Group's Q3 2022 Portfolio in Review
As of Q3 2022, UBS Group held 11,885 positions worth $228B, down 6.3% from $244B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
UBS Group's Q3 2022 filing shows 1,175 new, 4,825 increased, 3,846 reduced and 1,024 closed positions. Its largest new stake was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M. The largest sale was iShares MSCI ACWI ETF, an estimated $630M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q3 2022 buy was Fairlead Tactical Sector ETF: 824,803 shares worth $18.4M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $324M increase.
- UBS Group's biggest Q3 2022 reduction was iShares MSCI ACWI ETF, cutting an estimated $630M.
- UBS Group fully exited CMC Materials, Inc. Common Stock in Q3 2022, selling an estimated $111M.
- UBS Group's ten largest holdings make up 14% of its $228B portfolio in Q3 2022.
- UBS Group opened 1,175 new positions and closed 1,024 in Q3 2022.
- UBS Group's portfolio value fell 6.3% quarter-over-quarter to $228B.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.